Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated gram-negative bacteraemia (the invest trial): study protocol for a multicentre, randomised controlled, open-label, phase iii, non-inferiority trial

HIGHLIGHTS

• who: I. Russel Lee from the Department of Infectious Diseases, University of tion and Immunity, Melbourne, Victoria, Australia have published the Article: Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial, in the Journal: (JOURNAL) of 20/01/2022
• what: As current management of Gram-negative bacteraemia entails a duration of IV therapy with limited evidence to guide oral conu2011 the authors aim to evaluate the clinical efficacy and economic impact of early . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.